Molecular structure of Liraglutide, CAS Number: 204656-20-2
Liraglutide (CAS 204656-20-2)
Alternate Names:
NN 2211
CAS Number:
204656-20-2
Molecular Weight:
3751.2
Molecular Formula:
C172H265N43O51
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Liraglutide (CAS 204656-20-2) References
- Liraglutide and obesity: a review of the data so far. | Ladenheim, EE. 2015. Drug Des Devel Ther. 9: 1867-75. PMID: 25848222
- Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics. | Jacobsen, LV., et al. 2016. Clin Pharmacokinet. 55: 657-72. PMID: 26597252
- Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. | Blackman, A., et al. 2016. Int J Obes (Lond). 40: 1310-9. PMID: 27005405
- Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. | O'Neil, PM., et al. 2018. Lancet. 392: 637-649. PMID: 30122305
- Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial. | Wadden, TA., et al. 2020. Obesity (Silver Spring). 28: 529-536. PMID: 32090517
- Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. | Lundgren, JR., et al. 2021. N Engl J Med. 384: 1719-1730. PMID: 33951361
- Liraglutide attenuates hepatic iron levels and ferroptosis in db/db mice. | Song, JX., et al. 2022. Bioengineered. 13: 8334-8348. PMID: 35311455
- Liraglutide Attenuates Hepatic Ischemia-Reperfusion Injury by Modulating Macrophage Polarization. | Li, SL., et al. 2022. Front Immunol. 13: 869050. PMID: 35450076
- Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study. | Jensen, AB., et al. 2023. Obes Surg. 33: 1017-1025. PMID: 36765019
Inhibitor of:
apoA-IV, galectin-12, GPR119, Insulin, Olr192, Pancreatic Icosapeptide, Peptide YY3, PMVK, Prokineticin-2, and QRFP.Activator of:
AMAC1L1, apoA-V, CTRP4, GALK1, GIPR, Gl Syn, GLP-1R, GLP-2R, GLP1, HAL, INSL5, MafA, Ob-R, Pax-4, PCBD1, Peptide YY, and PPAR gamma.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Liraglutide, 1 mg | sc-507404 | 1 mg | $220.00 |